TFAM and Parkinson disease: TN-2 is a novel derivative of TMP, which could protect dopaminergic neurons against MPTP/MPP(+)-induced neurotoxicity possibly by increasing TFAM and activating mitochondrial biogenesis such as PGC-1α and β, indicating that TN-2 may be used to treat PD in future [52].